AC
AXSM icon

AXQ Capital’s Axsome Therapeutics AXSM Stock Holding History

AXQ Capital’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Buy
+1,332
New +$289K 0.04% 590
2024
Q3 		– Sell
-4,892
Closed -$394K – 433
2024
Q2 		$394K Buy
+4,892
New +$362K 0.09% 332
2024
Q1 		– Sell
-3,700
Closed -$294K – 622
2023
Q4 		$294K Buy
+3,700
New +$247K 0.08% 387

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AXQ Capital's AXSM Position: Q2 2026 in Review

AXQ Capital opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 1,332 shares worth $326K. The stake represents 0.04% of the portfolio and ranks #590 among its holdings. This is a return to the name: AXQ Capital previously reported a position in AXSM as recently as Q2 2024.

AXQ Capital first reported a position in AXSM in Q4 2023 and has held it in 3 quarters since. The position peaked at $394K in Q2 2024. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • AXQ Capital held 1,332 shares of Axsome Therapeutics worth $326K as of Q2 2026.
  • Axsome Therapeutics was a new AXQ Capital position in Q2 2026.
  • Axsome Therapeutics made up 0.04% of AXQ Capital's portfolio in Q2 2026, its #590 holding.
  • AXQ Capital first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • AXQ Capital's Axsome Therapeutics position peaked at $394K in Q2 2024.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.